“…While the other synthetic methods involve redox reactions to obtain Eu 2+ , the metathesis approach makes use of Eu 2+ halides and alkali‐metal‐containing ligands as precursors to generate the desired Eu 2+ ‐containing complex. The metathesis reaction has been successful in preparing several Eu 2+ ‐containing complexes including the bimetallic [Eu 2 (Ap*py) 3 I(THF)] ( 48 ), where Ap*py is deprotonated 6‐methylpyridin‐2‐yl‐[6‐(2,4,6‐triisopropylphenyl)pyridin‐2‐yl]amine,59 a monometallic Eu 2+ ‐containing trans ‐ N , N′ ‐dimethyl‐ meso ‐octaethylporphyrinogen complex ( 49 ),60 a Eu 2+ ‐containing benzamidinate complex [Eu{PhC{NSi(CH 3 ) 3 }{2,6‐(iPr) 2 NC 6 H 3 }} 2 (THF) 2 ] ( 50 ),61 a Eu 2+ complex with olefin‐substituted cyclopentadienyl ligands [{C 5 (CH 3 ) 4 Si(CH 3 ) 2 CH 2 CH=CH 2 } 2 Eu] ( 51 ),62 bis(diphosphanylamido) complex [{(Ph 2 P) 2 N} 2 Eu(THF) 3 ] ( 52 ),63 a Eu 2+ complex containing bis(phosphinimino)methanide ligands [{{(CH 3 ) 3 SiNPPh 2 } 2 CH}EuI(THF)] 2 ( 53 ),64 an aminotroponiminate complex of composition [{( i Pr) 2 ATI}Eu{N{Si(CH 3 ) 2 }}(THF) 2 ] ( 54 ), where ( i Pr) 2 ATI is N ‐isopropyl‐2‐(isopropylamino)troponiminate,65 and a monometallic, heteroleptic complex [(DIP 2 pyr)Eu(THF) 3 ] ( 55 ), where DIP 2 pyr is 2,5‐bis[( N ‐2,6‐diisopropylphenyl)iminomethyl]pyrrolyl (Figure 6). 66 Complexes 48 – 55 were prepared by the metathesis reaction of [EuI 2 (THF) x ], where labile THF, iodine, or both are displaced by the desired ligand.…”